Kawasaki disease: update on diagnosis, treatment, and a still controversial etiology.
Diagnosis of Kawasaki syndrome still relies solely on clinical criteria because the etiology is unknown. However, the function and structure of different bacterial superantigens as potential pathogens are discussed. In this regard, the recent determination of the crystal structure of the toxic shock syndrome toxin-1 superantigen complexed with major histocompatibility complex class II suggests potential implications for the controversial findings concerning a role of those superantigens in Kawasaki disease. Although a specific therapy is not available, coronary complications can be significantly reduced with the help of intravenous immunoglobulin therapy combined with oral aspirin.
Fischer
P
P
University Children's Hospital, DFG Clinical Research Group, Medical Faculty (Charité) of the Humboldt University, Berlin, Germany.
Uttenreuther-Fischer
M M
MM
Naoe
S
S
Gaedicke
G
G
D002648:Child; D002675:Child, Preschool; D006801:Humans; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis / Q000209:etiology / Q000628:therapy